SCHEMBL2480194

SCHEMBL2480194

CC(=O)N1CC(N2CCN(c3cc[c]cc3)CC2)C1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CASP6 P55212 1/20 0.45
▸ GFER P55789 1/20 0.45
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ MAPT P10636 2/20 0.42
▸ NPC1 O15118 2/20 0.42
▸ KDM4E B2RXH2 3/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ MBTD1 Q05BQ5 1/20 0.40
▸ TP53BP1 Q12888 1/20 0.40
▸ L3MBTL4 Q8NA19 1/20 0.40
▸ L3MBTL3 Q96JM7 1/20 0.40
▸ USP2 O75604 1/20 0.39
▸ HRH3 Q9Y5N1 2/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ TSHR P16473 1/20 0.38
▸ RAB9A P51151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188211 0.82 GFER (0.64) CASP6GFERKMT2AMEN1MAPT
SCHEMBL1815274 0.82 GFER (0.69) CASP6GFERKMT2AMEN1MAPT
SCHEMBL1814321 0.78 MEN1 (0.62) KMT2AMEN1MAPTALDH1A1
SCHEMBL2507401 0.77 GFER (0.57) CASP6GFERKMT2AMEN1MAPT
SCHEMBL1811223 0.76 L3MBTL3 (0.57) KMT2AMEN1MAPTL3MBTL1MBTD1
SCHEMBL1815476 0.73 L3MBTL3 (0.58) KMT2AL3MBTL1MBTD1TP53BP1L3MBTL4
SCHEMBL27879361 0.72 L3MBTL3 (0.53) KMT2AMAPTL3MBTL1MBTD1TP53BP1
SCHEMBL3963086 0.71 L3MBTL3 (0.56) L3MBTL1MBTD1L3MBTL3HRH3
SCHEMBL20522873 0.71 L3MBTL3 (0.43) KMT2AL3MBTL1MBTD1L3MBTL3ALDH1A1
SCHEMBL2479134 0.71 NOTUM (0.45) KMT2AMEN1MAPTKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2376493-B1 DIHYDROPYRIMIDOPYRIMIDINE DERIVATIVE MSD KK (JP) 2016-10-05 — — EP disclosed
US-8575179-B2 Dihydropyrazolopyrimidinone derivatives MSD K.K. (JP) 2013-11-05 — — US disclosed
US-8507505-B2 Dihydropyrazolopyrimidinone derivative MSD K.K. (JP) 2013-08-13 — — US disclosed
EP-2376494-A1 DIHYDROPYRIMIDOPYRIMIDINE DERIVATIVES MSD K.K. (JP) 2011-10-19 — — EP disclosed
EP-2376493-A1 DIHYDROPYRIMIDOPYRIMIDINE DERIVATIVE MSD K.K. (JP) 2011-10-19 — — EP disclosed
US-20110243891-A1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVE MSD K.K. 2011-10-06 — — US disclosed
US-20110245229-A1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVES MSD K.K. (JP) 2011-10-06 — — US disclosed
WO-2010067886-A1 DIHYDROPYRIMIDOPYRIMIDINE DERIVATIVE BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-06-17 — — WO disclosed
WO-2010067888-A1 DIHYDROPYRIMIDOPYRIMIDINE DERIVATIVES BANYU PHARMACEUTICAL CO.,LTD. (JP) 2010-06-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245229-A1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVES WEE2, WEE1, CDKL1 CASP6 3069/4885GFER 3176/4885KMT2A 2298/4885
US-20110243891-A1 DIHYDROPYRAZOLOPYRIMIDINONE DERIVATIVE WEE2, WEE1, RPS6KA1 CASP6 2987/4885GFER 3604/4885KMT2A 2167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback